.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A01A_StomatologicalPreparations.A01AC04_Prednisolone.Prednisolone .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A01A_StomatologicalPreparations.A01AC04_Prednisolone.Prednisolone| name: | Prednisolone |
| ATC code: | A01AC04 | route: | oral |
| n-compartments | 2 |
Prednisolone is a synthetic glucocorticoid and anti-inflammatory agent widely used in the treatment of a variety of conditions including asthma, rheumatoid arthritis, autoimmune disorders, inflammatory diseases, and allergies. It is an active metabolite of prednisone and is approved and in common clinical use today.
Pharmacokinetic parameters for healthy adult volunteers after a single oral dose.
de Truchis, C, et al., & Boyer, O (2023). Prednisolone pharmacokinetics after oral prednisone administration in paediatric patients with kidney transplant. British journal of clinical pharmacology 89(5) 1532–1540. DOI:10.1111/bcp.15610 PUBMED:https://pubmed.ncbi.nlm.nih.gov/36510685
Petersen, KB, et al., & Schmiegelow, K (2003). Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia. Cancer chemotherapy and pharmacology 51(6) 465–473. DOI:10.1007/s00280-003-0602-3 PUBMED:https://pubmed.ncbi.nlm.nih.gov/12698270
Yoshida, K, et al., & Chanu, P (2021). Population Pharmacokinetics of Ipatasertib and Its Metabolite in Cancer Patients. Journal of clinical pharmacology 61(12) 1579–1591. DOI:10.1002/jcph.1942 PUBMED:https://pubmed.ncbi.nlm.nih.gov/34273118